NCT06611462 (STRONG-Hernia) is a NA clinical trial of Prehabilitation (the STRONG programme) in Ventral Hernia, sponsored by Bispebjerg Hospital.

Who is sponsoring NCT06611462?

NCT06611462 is sponsored by Bispebjerg Hospital.

What drugs are being tested in NCT06611462?

Interventions in NCT06611462: Prehabilitation (the STRONG programme).

What condition does NCT06611462 study?

NCT06611462 studies Ventral Hernia, Surgery, Risk Reduction, Lifestyle, Postoperative Complications, Prehabilitation.

Is NCT06611462 still recruiting?

NCT06611462 is currently recruiting now. Last updated 25 September 2024.

Last reviewed 2024-09-25 · How we verify

NCT06611462: STRONG-Hernia

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

STRONG for Surgery & Strong for Life - Intensive Prehabilitation for Risk Reduction in Ventral Hernia Repair

Recruiting now NA Last updated 25 September 2024

What this trial tests

NA trial testing Prehabilitation (the STRONG programme) in Ventral Hernia in 400 participants. Currently enrolling.

Timeline

4 March 2024

Primary endpoint
1 March 2026

1 March 2028

Quick facts

Lead sponsor	Bispebjerg Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	400
Start date	4 March 2024
Primary completion	1 March 2026
Estimated completion	1 March 2028
Sites	3 locations across Denmark

Drugs / interventions tested

Prehabilitation (the STRONG programme)

Conditions studied

Ventral Hernia — all drugs for Ventral Hernia →
Surgery — all drugs for Surgery →
Risk Reduction — all drugs for Risk Reduction →
Lifestyle — all drugs for Lifestyle →

Sponsor

Bispebjerg Hospital

Who can join

18 and older, any sex, with Ventral Hernia or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The five risky lifestyles Smoking, Nutrition (obesity and malnutrition), risky Alcohol intake, and Physical inactivity (SNAP) are common in surgical patients and associated with worse postoperative outcomes. Mono-factor interventions targeting and improving these risky lifestyles have been shown to reduce the risk at surgery, but there is a lack of systematic assessment of all five lifestyles of the patient before surgery and related optimization. This study aims to evaluate the effect of intensive combined lifestyle interventions (the STRONG programme) compared with treatment as usual in patients undergoing ventral hernia repair on postoperative complications, health, and costs on short and longer term. The hypothesis is that the STRONG programme will halve the complication rates within 30 days.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of tailored, intensive prehabilitation for risky lifestyles before ventral hernia repair on postoperative outcomes, health, and costs - study protocol for a randomised controlled trial (STRONG-Hernia).
Jensen SAS, Lauridsen SV, Fonnes S, Rosenberg J, et al · · 2025 · cited 4× · PMID 40435308 · DOI 10.1371/journal.pone.0324002

Verify or expand the search:

Other recruiting trials for Ventral Hernia

Currently open trials in the same condition.

NCT06710795 — AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair · NA · active not recruiting
NCT06367309 — ExtrAperitoneaL Plasty vs Intraperitoneal oNlay mEsh in Ventral Hernia Repair · NA · recruiting
NCT06445504 — Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair) · NA · active not recruiting
NCT05682742 — Clinical Investigation of the da Vinci Surgical System · NA · active not recruiting
NCT05472987 — Robotic Versus Open Ventral Hernia Repair · NA · recruiting

Other Bispebjerg Hospital trials

Trials by the same sponsor.

NCT06872060 — The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance. · NA · not yet recruiting
NCT07373587 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy · NA · not yet recruiting
NCT07123558 — Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men · NA · not yet recruiting
NCT07124338 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy, a Feasibili · NA · active not recruiting
NCT07096648 — Alert Burden When Monitoring Patients at Home · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06611462 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bispebjerg Hospital
Last refreshed: 25 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06611462.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing